You Are Invited!   
Ready to experience an event that’s all about YOU? HOPE Summit is where lung cancer survivors and caregivers come together to connect, learn, and thrive. Think of it as a weekend filled with inspiration, knowledge, and a whole lot of hugs and high-fives. This year's event takes place May 2-4 in Bethesda, MD, and is free to attend. Registration is now open! Learn more. 

New Hope for Treating RET+ Cancers: A Live Discussion 

Discover groundbreaking cancer research! Join our Facebook Live event to explore protein degraders, a promising new approach for treating RET-positive cancer. Hear from patient advocates and experts, including Justin Drake, PhD, a leading researcher at the University of Minnesota. Dr. Drake, the 2024 RETpositive/LUNGevity awardee, will explain how these innovative therapies work, offering hope for those with RET-driven cancers. We hope to see you on March 28 at 12-1 pm ET at Facebook.com/LUNGevity.

Join Us for the Rare Mutations Virtual Meetup 
This is an easy way to build your community. On the first Wednesday of each month, you can connect with others who understand what it’s like to live with lung cancer with rare mutations and fusions. The next Rare Mutations Meetup is happening on Wednesday, April 2, at 3 pm ET.

Register for this virtual meetup to get a confirmation email with details about how to join the virtual meeting. New attendees are always welcome and encouraged to join! Can’t make it? Don’t worry, there’s a full list of virtual meetups to fit your schedule.

Brain Mets Basics for NSCLC   
Learn all about brain metastases in NSCLC from an expert in the field. Don’t miss the sections dedicated to treating brain mets in people with rare lung cancer biomarkers, including MET, NTRK, RET and ROS1. Watch here.

Significant Weight Loss During Treatment  
Losing significant weight and muscle mass during lung cancer treatment is common. However, often these symptoms are not a side effect of treatment. They can be due to a condition called cachexia. Learn more about this condition—including who is at risk for it, how to recognize it, and what can be done to address the symptoms.

Treatment News for RET+ NSCLC 
Learn about FDA-approved treatments for RET-positive lung cancer from John Heymach, MD, PhD, an internationally acclaimed physician-scientist, who also discusses important research in the field. In this panel discussion, patient advocates share their perspectives on how everyone with lung cancer has something to contribute—their experiences! Watch here.

Understanding Clinical Trials: Three-Part Series    
This series on clinical trials explains how drugs get approved by the FDA and become available to you.

Part 1: Why Are Clinical Trials Important for Drug Development?

Part 2: How Do We Define Success for Clinical Trials? 

Part 3: How Do Drugs Get Approved (and Fast-Tracked) by the FDA?

… and there is always so much more to explore on the Rare Mutations & Fusions Patient Gateway.

If you were forwarded this email and you’d like to subscribe to this newsletter, you can sign up here.

If you are looking for more LUNGevity Foundation news, check out LUNGevity’s monthly newsletter.

If you need further assistance along your lung cancer journey, please email us at support@lungevity.org. Our team is always here to assist you.